Tech Company Financing Transactions
PharmatrophiX Funding Round
PharmatrophiX closed a $10.3 million financing round on 11/23/2015. Backers included private investors.
Transaction Overview
Company Name
Announced On
11/23/2015
Transaction Type
Debt
Amount
$10,300,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2300 Wells Fargo Capitol Center
Raleigh, NC 27601
USA
Raleigh, NC 27601
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
PharmatrophiX is a biotech working on drugs that prevent neurodegenerative disease. Founded by Stanford researcher Frank Longo, PharmatrophiX is developing a class of drugs that mimic the activity of proteins called neurotrophins, which aid in the development, health and survival of neurons.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Anne Longo
Chief Financial Officer
John Autrey
Browse more venture capital transactions:
Prev: 11/23/2015: Fundrise venture capital transaction
Next: 11/23/2015: HealthCrowd venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs